Clinical outcomes | Group L ,n = 44 | Group H ,n = 44 | P value |
---|---|---|---|
Primary outcome | |||
MMSE(T1) | 26.0(24.0–27.0) | 24.5(22.0–26.0) | 0.046 |
MMSE(T2) | 27.0(25.0–29.0) | 27.0(25.0–28.0) | 0.293 |
MMSE (T3) | 28.0(26.0–29.0) | 27.0(25.3–28.8) | 0.344 |
MMSE (T4) | 28.0(26.0–29.0) | 27.5(27.0–29.0) | 0.148 |
Secondary outcome | |||
POD n (%) | 3(6.8) | 3(6.8) | > 0.999# |
Intraoperative hypotension n (%) | 2(4.5) | 8(18.2) | 0.044 |
Intraoperative bradycardia n (%) | 4(9.1) | 11(25.0) | 0.047 |
hours of initial intubation (h) | 19.5(15.0–23.0) | 21.0(15.0-27.8) | 0.415 |
Myocardial infarction n (%) | 0(0) | 0(0) | |
Stroke n (%) | 0(0) | 0(0) | |
CSICU stay(h) | 32.5(21.0–45.0) | 40.5(21.3–61.3) | 0.613 |
Hospital days (d) | 24.5(20.-329.8) | 23.0(18.0 -27.8) | 0.207 |
Hospital mortality n (%) | 0(0) | 0(0) |